Notice: Survey on the Impact of the 2024 Medical Fee Revision on Medical Corporations – M&A Capital Partners

Significance of the Survey on the Impact of the FY2024 Medical Fee Revision

The survey on the impact of the FY2024 medical fee revision on medical corporations, conducted by M&A Capital Partners, offers crucial insights for management in the medical industry. This revision goes beyond mere fee adjustments, entailing structural changes such as stricter facility standards and expanded utilization of regional medical collaboration promotion corporations, directly affecting the revenue structure and management strategies of individual medical institutions.

Key Considerations for M&A and Business Succession

The acceleration of these regulatory trends prompts medical institution managers, especially those facing succession issues, to reconsider the timing and methods of business succession. The importance of mid-to-long-term management strategies, considering the medical fee revision cycle, and consequently, succession strategies, is increasing. Specifically, mergers and group formations aimed at pursuing economies of scale, maintaining facility standards, and distributing facility investment burdens can be viable options. Furthermore, exploring tax schemes, including transitions to specific medical corporations or social medical corporations, is essential for maximizing the benefits of business succession.

Insights for Managers and Successors

In the rapidly evolving medical industry, institutional changes like medical fee revisions indicate that maintaining the status quo is becoming increasingly difficult. It is imperative to objectively analyze one's own institution's management status and concretely integrate the revision details into the business succession plan. Considering options such as M&A or group formation from an early stage, and exploring the optimal form of succession for one's institution through consultation with experts, will be key to maintaining a sustainable healthcare delivery system.